Top 5 Medical AI Companies

2. Pfizer Inc. (NYSE:PFE)

Market Cap: $187.2B

Being a leader and dominant player in the industry gives Pfizer Inc. (NYSE:PFE) an edge in the market when it comes to the AI race. Pfizer Inc. (NYSE:PFE) is pouring resources and money to use AI to optimize its operations, technology and drug pipeline. Pfizer Inc. (NYSE:PFE) is developing an “ML Research Hub” to create predictive models and tools for drug discovery.

Diamond Hill Large Cap Strategy made the following comment about Pfizer Inc. (NYSE:PFE) in its Q2 2023 investor letter:

“Our bottom contributors in Q2 included health insurance company Humana, biopharmaceutical company Pfizer Inc. (NYSE:PFE) and global entertainment company Disney. Pharmaceutical giant Pfizer has been dealing with a decline in sales due to lower COVID vaccination levels. Additionally, in 2023, management is increasing spend as the company invests in new product launches. That said, we remain positive about the long-term company fundamentals.”